Global $3.67B Smart Inhalers Market, 2026: Key Industry Insights & Projections – ResearchAndMarkets.com

Smart Inhalers Market Size, Market Share, Application Analysis, Regional
Outlook, Growth Trends, Key Players, Competitive Strategies and
Forecasts, 2018 To 2026”
report has been added to ResearchAndMarkets.com’s

The global smart inhalers market was valued at US$ 1,006.6 Mn in 2017
and is expected to reach US$ 3,674.6 Mn by 2026, expanding at a CAGR of
15.7% from 2018 to 2026.

Market Insights

According to the research findings of the World Health Organization
(WHO), chronic obstructive pulmonary disease is responsible for 5% of
global deaths annually. There is no permanent cure for chronic
respiratory illness such as COPD, asthma, and bronchitis. Immediate
symptomatic relief provided by respiratory inhalation is the best
possible cure, hence smart inhalers possess impressive market growth in
the near future due to excellent patient adherence and compliance to the
treatment regimen.

Metered dose inhalers (MDIs) are reigning the type segment for smart
inhalers market. Excellent PK/PD profile achieved during the drug
delivery and increasing demand in geriatric patients suffering from
chronic illness drive the metered dose inhalers market growth.

Dry powder inhalers have gained tremendous attraction in recent times
due to the drug irritation and severe adverse effects caused by the
propellants employed in MDIs. Nebulizers are widely employed in
pediatric patients due to higher safety and efficacy associated with the
drug delivery system.

Chronic obstructive pulmonary disease is currently leading the
application segment for smart inhalers market. The rampant growth of
smokers in developed countries and rising industrialization in
developing nation has led to the rise of air pollution and exposure to
occupational dust and fumes. Asthma will be the fastest growing market
in the near future due to the rising prevalence of hereditary asthma in
children and requires immediate symptomatic relief due to constriction
of respiratory muscles.

In the present scenario, North America with a share of 38% is leading
the regional segment for smart inhalers market. The key features that
contribute towards its supremacy are rampant growth in tobacco smokers
and domicile of major players such as Propeller Health, Cohero Health,
3M Healthcare etc.

Europe accounts for 29% market share, on account of the increasing
number of pediatric patients suffering from asthma and strategic
collaboration between pharmaceutical giants and software companies to
provide a smart inhaler system.

The Asia Pacific with a market share of 20% will be the fastest growing
regional segment during the forecast period on account of increasing
geriatric patients suffering from chronic pulmonary illness and
emergence of local players exerting stringent competition to western
giants in smart inhalers market.

Companies in collaboration with pharmaceutical key players engaged in
the development of smart inhalers are Amiko, Adherium Limited, Cohero
Health, 3M Healthcare, Opko Health, Inc., Propeller Health, Philips
Respironics, Sensirion AG, Teva Pharmaceutical Industries Limited and
Vectura Group, Plc.

Key Market Movements

  • An increasing number of geriatric patients suffering from chronic
    respiratory illness
  • A significant increase in the number of tobacco smokers and rising air
  • A recent launch of innovative smart apps and wireless services to
    enhance drug delivery and patient compliance

Topics Covered

Chapter 1. Preface

1.1. Report Scope and Description

1.2. Research Scope

1.3. Research Methodology

1.4. Market Segmentation

Chapter 2. Executive Summary

2.1. Global Smart Inhalers Market Portraiture

2.2. Global Smart Inhalers Market, by Type, 2017 (US$ Mn)

2.3. Global Smart Inhalers Market, by Application, 2017 (US$ Mn)

2.4. Global Smart Inhalers Market, by Geography, 2017 (US$ Mn)

Chapter 3. Smart Inhalers Market: Dynamics and Future Outlook

3.1. Market Overview

3.2. Drivers

3.3. Challenges

3.4. Opportunities

3.5. Attractive Investment Proposition, by Geography, 2017

3.6. Competitive Analysis: Global Smart Inhalers Market, by Key Players,

Chapter 4. Global Smart Inhalers Market, by Type

4.1. Overview

4.2. Metered Dose Inhalers

4.3. Dry Powder Inhalers

4.4. Nebulizers

Chapter 5. Global Smart Inhalers Market, by Application

5.1. Overview

5.2. Chronic Obstructive Pulmonary Disease (COPD)

5.3. Asthma

5.4. Others

Chapter 6. Global Smart Inhalers Market, by Geography

6.1. Overview

6.2. North America Smart Inhalers Market Analysis, 2016 – 2026

6.3. Europe Smart Inhalers Market Analysis, 2016 – 2026

6.4. Asia Pacific Smart Inhalers Market Analysis, 2016 – 2026

6.5. Latin America Smart Inhalers Market Analysis, 2016 – 2026

6.6. Middle East and Africa Smart Inhalers Market Analysis, 2016 – 2026

Chapter 7. Company Profiles

7.1. Amiko

7.1.1. Business Description

7.1.2. Financial Information (Subject to data availability)

7.1.3. Product Portfolio

7.1.4. News Coverage

7.2. Adherium Limited

7.3. Cohero Health

7.4. 3M Healthcare

7.5. Opko Health Inc.

7.6. Propeller Health

7.7. Philips Respironics

7.8. Sensirion AG

7.9. Teva Pharmaceutical Industries Ltd.

7.10. Vectura Group PLC

For more information about this report visit https://www.researchandmarkets.com/r/5h5zhf


Laura Wood, Senior Press Manager
[email protected]
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Topics: Inhalers
and Nebulisers
, Respiratory

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.